Francisco J. Godinez-Padilla

Tlaquepaque, JAL 45604, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Synaptic Vesicle Disruption in Parkinson's Disease: Dual Roles of α-Synuclein and Emerging Therapeutic Targets.

Synaptic Vesicle Disruption in Parkinson's Disease: Dual Roles of α-Synuclein and Emerging Therapeutic Targets.

Journal: Brain sciences

Published: November 27, 2025

Decoding the structural and functional diversity of GABAA receptors: from ensemble logic to therapeutic opportunities.

Decoding the structural and functional diversity of GABAA receptors: from ensemble logic to therapeutic opportunities.

Journal: Frontiers in pharmacology

Published: September 02, 2025

α-Synuclein Pathology in Synucleinopathies: Mechanisms, Biomarkers, and Therapeutic Challenges.

α-Synuclein Pathology in Synucleinopathies: Mechanisms, Biomarkers, and Therapeutic Challenges.

Journal: International journal of molecular sciences

Published: April 25, 2025

Dopamine stabilized in ultra-nanoreservoirs for controlled delivery in parkinson's disease.

Dopamine stabilized in ultra-nanoreservoirs for controlled delivery in parkinson's disease.

Journal: Nanomedicine (London, England)

Published: February 12, 2025

α-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies.

α-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies.

Journal: Frontiers in neuroscience

Published: February 03, 2025

Alpha-Synuclein Gene Alterations Modulate Tyrosine Hydroxylase in Human iPSC-Derived Neurons in a Parkinson's Disease Animal Model.

Alpha-Synuclein Gene Alterations Modulate Tyrosine Hydroxylase in Human iPSC-Derived Neurons in a Parkinson's Disease Animal Model.

Journal: Life (Basel, Switzerland)

Published: May 05, 2024

Effect of catalytic nanomedicine on amputation-stage chronic venous ulcers: four case studies.

Effect of catalytic nanomedicine on amputation-stage chronic venous ulcers: four case studies.

Journal: Wound management & prevention

Published: December 13, 2023

Solid CaCO3 Formation in Glioblastoma Multiforme and its Treatment with Ultra-Nanoparticulated NPt-Bionanocatalysts.

Solid CaCO3 Formation in Glioblastoma Multiforme and its Treatment with Ultra-Nanoparticulated NPt-Bionanocatalysts.

Journal: Current cancer drug targets

Published: October 23, 2023

Catalytic Nanomedicine as a Therapeutic Approach to Brain Tumors: Main Hypotheses for Mechanisms of Action.

Catalytic Nanomedicine as a Therapeutic Approach to Brain Tumors: Main Hypotheses for Mechanisms of Action.

Journal: Nanomaterials (Basel, Switzerland)

Published: April 01, 2023

Embryoid Body Cells from Human Embryonic Stem Cells Overexpressing Dopaminergic Transcription Factors Survive and Initiate Neurogenesis via Neural Rosettes in the Substantia Nigra.

Embryoid Body Cells from Human Embryonic Stem Cells Overexpressing Dopaminergic Transcription Factors Survive and Initiate Neurogenesis via Neural Rosettes in the Substantia Nigra.

Journal: Brain sciences

Published: December 22, 2022

Nanomedicine in the Face of Parkinson's Disease: From Drug Delivery Systems to Nanozymes.

Nanomedicine in the Face of Parkinson's Disease: From Drug Delivery Systems to Nanozymes.

Journal: Cells

Published: October 04, 2022

Catalytic nanomedicine: a brief review of bionanocatalysts.

Catalytic nanomedicine: a brief review of bionanocatalysts.

Journal: Nanomedicine (London, England)

Published: September 14, 2022

Showing 1-12 of 15

Last Updated: 09/26/2026